<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-29T20:18:53+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>博安生物估值48.5亿融资，下一步独立上市？</title>
    <updated>2020-12-29T17:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/2m_8WJXdVaNgu0XMhqE5_w</id>
    <link href="https://mp.weixin.qq.com/s/2m_8WJXdVaNgu0XMhqE5_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声重磅产品先必新进入医保目录 竞逐千亿脑卒中市场</title>
    <updated>2020-12-29T17:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/_eUVUgplF7bQ9TZGy7cntg</id>
    <link href="https://mp.weixin.qq.com/s/_eUVUgplF7bQ9TZGy7cntg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1医保谈判平均降幅达78%</title>
    <updated>2020-12-29T17:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/3S0IoN8ua1sW6bO2hJ89ng</id>
    <link href="https://mp.weixin.qq.com/s/3S0IoN8ua1sW6bO2hJ89ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和黄医药向FDA提交索凡替尼上市申请</title>
    <updated>2020-12-29T17:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/lOam_Dy_bQqOrYyhTJOa9w</id>
    <link href="https://mp.weixin.qq.com/s/lOam_Dy_bQqOrYyhTJOa9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第3家！正大天晴「马来酸阿法替尼片」获批上市</title>
    <updated>2020-12-29T17:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/63H93opxgk5bF0fvBNMukw</id>
    <link href="https://mp.weixin.qq.com/s/63H93opxgk5bF0fvBNMukw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首家过评！石药欧意「达沙替尼片」即将获批上市</title>
    <updated>2020-12-29T17:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/cc6vtRv9ZS3u3DZuLU19Jg</id>
    <link href="https://mp.weixin.qq.com/s/cc6vtRv9ZS3u3DZuLU19Jg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲「度普利尤单抗」新适应症获批临床</title>
    <updated>2020-12-29T17:07:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/cMvjMczta6NJfgEHOiWEpQ</id>
    <link href="https://mp.weixin.qq.com/s/cMvjMczta6NJfgEHOiWEpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤患者福音：K药援助方案再升级，14万兜底保终身！</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/_qOijNTHjs4MZkefV-SuDA</id>
    <link href="https://mp.weixin.qq.com/s/_qOijNTHjs4MZkefV-SuDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>绿叶制药与阿斯利康再度战略携手 积极推进心血管及肿瘤领域的深度合作</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/q_n0QeFc2_pXk3xp7Q-TkQ</id>
    <link href="https://mp.weixin.qq.com/s/q_n0QeFc2_pXk3xp7Q-TkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020医保谈判独家品种信息汇总（附部分品种降幅）</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/WXtX50ucXF-DwPtcju88YQ</id>
    <link href="https://mp.weixin.qq.com/s/WXtX50ucXF-DwPtcju88YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维迪西妥单抗获CDE突破性治疗认可，有望填补HER2阳性尿路上皮癌治疗空白</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/1cRQr3wudA4KVwhmRj04CQ</id>
    <link href="https://mp.weixin.qq.com/s/1cRQr3wudA4KVwhmRj04CQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>进医保最快创新药TOP20</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/MoFNFxmKTC0ahhRrkTqOJA</id>
    <link href="https://mp.weixin.qq.com/s/MoFNFxmKTC0ahhRrkTqOJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10个单抗首次医保谈判成功，13个续签</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/3cjhv1c0mXL2FwOlb346dQ</id>
    <link href="https://mp.weixin.qq.com/s/3cjhv1c0mXL2FwOlb346dQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大战！6款GLP-1受体激动剂纳入医保目录</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/JyiUKhYPa35JpAKK22cKNg</id>
    <link href="https://mp.weixin.qq.com/s/JyiUKhYPa35JpAKK22cKNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方核心行业数据监测周报（12月19-25日）</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/AuQ7rFW3UE6Fqc6b6uHkqg</id>
    <link href="https://mp.weixin.qq.com/s/AuQ7rFW3UE6Fqc6b6uHkqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>河南带量采购公布29个品种拟中标结果</title>
    <updated>2020-12-27T10:24:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/f-mxHpIxQZvokpqgGgE_Ow</id>
    <link href="https://mp.weixin.qq.com/s/f-mxHpIxQZvokpqgGgE_Ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年具有里程碑意义的临床研究TOP10</title>
    <updated>2020-12-27T10:24:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/ZifFNR9wQGhQFWHaMiC5oA</id>
    <link href="https://mp.weixin.qq.com/s/ZifFNR9wQGhQFWHaMiC5oA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年，这6家医药公司终止科创板上市</title>
    <updated>2020-12-26T10:03:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/cY2GxMfsKmiyvZyxFR9r8Q</id>
    <link href="https://mp.weixin.qq.com/s/cY2GxMfsKmiyvZyxFR9r8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点：2020年FDA批准的新药</title>
    <updated>2020-12-26T10:03:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/a2KL7BoEMqJDG7rDfcPDtQ</id>
    <link href="https://mp.weixin.qq.com/s/a2KL7BoEMqJDG7rDfcPDtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年失败临床研究TOP10</title>
    <updated>2020-12-26T10:03:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/3LJl_Mt3QhRZZNIhIel6aA</id>
    <link href="https://mp.weixin.qq.com/s/3LJl_Mt3QhRZZNIhIel6aA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>